ANALISIS EFEK PENGGUNAAN RAMIPRIL DAN CANDESARTAN PADA PASIEN RAWAT INAP PENDERITA COVID-19 DENGAN KOMORBID HIPERTENSI DI RSUD dr. MOEWARDI TAHUN 2020

Azizah, Deva Yolanda Dwi Nur (2022) ANALISIS EFEK PENGGUNAAN RAMIPRIL DAN CANDESARTAN PADA PASIEN RAWAT INAP PENDERITA COVID-19 DENGAN KOMORBID HIPERTENSI DI RSUD dr. MOEWARDI TAHUN 2020. Skripsi thesis, Universitas Setia Budi.

	Text 1. ABSTRAK.pdf Download (186kB)
	Text 4. BAB I.pdf Download (519kB)
	Text 5. BAB II.pdf Restricted to Repository staff only Download (552kB) | Request a copy
	Text 6. BAB III.pdf Restricted to Repository staff only Download (205kB) | Request a copy
	Text 7. BAB IV.pdf Restricted to Repository staff only Download (355kB) | Request a copy
	Text 8. BAB V.pdf Restricted to Repository staff only Download (186kB) | Request a copy
	Text 9. DAFTAR PUSTAKA.pdf Download (654kB)
	Text 10. LAMPIRAN.pdf Download (322kB)
	Text 2. FORM PERNYATAAN PUBLIKASI.pdf Download (433kB)
	Text 3. SURAT KETERANGAN BEBAS PLAGIASI (perpustakaan).pdf Download (22kB)

Abstract

Hypertension is the most common comorbid in patients infected by COVID- 19. Drugs that are often given for the treatment of hypertension, namely ramipril and candesartan, are thought to increase the development of COVID-19 because the angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARBs) increase the expression of ACE-2, which is the binding site of SARS-CoV-2. This study aims to analyze the effect of using ramipril and candesartan on healing in hospitalized patients with COVID-19 with hypertension at RSUD dr. Moewardi in 2020. This study was conducted retrospectively. The results were presented descriptively, and used medical record data of hospitalized patients with COVID- 19 with comorbid hypertension at RSUD dr. Moewardi in 2020. The effect of using ramipril and candesartan on patient recovery in terms of length of stay (LOS), symptom relief, and RT-PCR test results. Analysis of the research data using SPSS with Spearman correlation test. The Spearman correlation test showed that there was a fairly strong relationship between the use of ramipril and candesartan in patients with COVID- 19 with comorbid hypertension on LOS, symptom relief, and RT-PCR test results. From the results of the study, it can be concluded that the use of ramipril and candesartan can improve the recovery of patients COVID-19 with comorbid hypertension. The use of ACEI and ARB drugs has not been proven to worsen the patient's condition so that their use can be continued. Key words: COVID-19, hypertension, hypertension in COVID-19, ramipril, candesartan

Item Type:	Thesis (Skripsi)
Uncontrolled Keywords:	COVID-19, hypertension, hypertension in COVID-19, ramipril, candesartan
Subjects:	R Medicine > R Medicine (General)
Divisions:	Fakultas Farmasi > Prodi S1 Farmasi
Depositing User:	Tifany Nur Arfiana
Date Deposited:	29 Sep 2022 04:38
Last Modified:	29 Sep 2022 04:38
URI:	http://repo.setiabudi.ac.id/id/eprint/5272

Actions (login required)

View Item